The Biologics News and Reports Portal

Show Cart

All Products

Results 181 - 193 of 193

Sep 2010 Coagulation Factors 2010 - The Portfolio Aspect as Decisive Force: A Competitive Landscape and R&D Pipeline Analysis of Hemostasis Proteins

2,495.00 €

Aug 2009 Coagulation Factors 2009: Target Pipeline and Corporate Benchmark Analysis

2,450.00 €

Apr 2009 Competitor Analysis: Hypoxia-Inducible Factor (HIF)

100.00 €

Sep 2008 Competitor Analysis: HDL Raising Therapies

250.00 €

Oct 2005 R&D Pipeline News - Technology Edition: 1-Yr Subscription

900.00 €

Oct 2005 R&D Pipeline News - Therapeutic Area Edition: 1-Yr Subscription

900.00 €

Start
Prev
1
2
3
4
5
6
7
8
9
10
Next
End

Shopping cart

Cart empty

Latest report

Cadherin 17: A target opportunity to develop effector-enhanced drug modalities

Featured Products

Targeted Protein Degradation by Proteasomal, Lysosomal & Autophagy Pathways 2022: an industry landscape analysis of stakeholders, technologies, pipeline, partnering and financing

Masked Antibodies & Cytokines As Prodrugs:a landscape analysis of stakeholders, technologies, pipelines, business and financing from an industry perspective

Vectorized Antibodies for In Vivo Expression by DNA and mRNA: a landscape analysis of stakeholders, technologies, targets, business and financing from an industry perspective

Latest Target Pipeline

Claudin 6: A target opportunity to develop effector-enhanced drug modalities

Shopping cart

Cart empty

Latest report

Cadherin 17: A target opportunity to develop effector-enhanced drug modalities

Featured Products

Targeted Protein Degradation by Proteasomal, Lysosomal & Autophagy Pathways 2022: an industry landscape analysis of stakeholders, technologies, pipeline, partnering and financing

Masked Antibodies & Cytokines As Prodrugs:a landscape analysis of stakeholders, technologies, pipelines, business and financing from an industry perspective

Vectorized Antibodies for In Vivo Expression by DNA and mRNA: a landscape analysis of stakeholders, technologies, targets, business and financing from an industry perspective

All Products

Aug 2011 Competitor Analysis: Targeted Therapy of Hepatitis C

Jun 2011 Competitor Analysis: Hepatitis Vaccines

May 2011 Competitor Analysis: Influenza Vaccines

Apr 2011 Competitor Analysis: Targeted Therapy of Diabetes

Apr 2011 Competitor Analysis: Emerging Diabetes Drugs

Mar 2011 Competitor Analysis: Targeted Therapy of Obesity

Nov 2010 Antibody Technology Companies 2010

Sep 2010 Coagulation Factors 2010 - The Portfolio Aspect as Decisive Force: A Competitive Landscape and R&D Pipeline Analysis of Hemostasis Proteins

Aug 2009 Coagulation Factors 2009: Target Pipeline and Corporate Benchmark Analysis

Apr 2009 Competitor Analysis: Hypoxia-Inducible Factor (HIF)

Sep 2008 Competitor Analysis: HDL Raising Therapies

Oct 2005 R&D Pipeline News - Technology Edition: 1-Yr Subscription

Oct 2005 R&D Pipeline News - Therapeutic Area Edition: 1-Yr Subscription

Shopping cart

Latest report

Featured Products

Latest Target Pipeline

Shopping cart

Latest report

Featured Products

Latest Target Pipeline

La Merie Biologics

FREE Weekly News Bulletin

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing